ACE Report Cover
Caudal Versus Transforaminal Epidural Steroid Injection for Unilateral S1 Radiculopathy
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SPINE
Caudal Versus Transforaminal Epidural Steroid Injection for Unilateral S1 Radiculopathy .

Caudal epidural steroid injection versus transforaminal ESI for unilateral S1 radiculopathy: a prospective, randomized trial.

Pain Med . 2023 Aug 1;24(8):957-962.
Contributing Authors

EC Ozturk R Sacaklidir S Sencan OH Gunduz

62 patients with L5-S1 paracentral disc herniation causing unilateral S1 radicular pain were randomized to receive either a caudal epidural steroid injection (caudal ESI; n=31) or a transforaminal epidural steroid injection (S1 TFESI; n=31). Outcomes of interest included procedural time, radiation dose, pain on a Numeric Rating Scale (NRS), Oswestry Disability Index (ODI), and the incidence of ≥50% improvement in NRS. Procedure time and radiation dose were significantly lower in the caudal ESI group, whereas all other outcomes were similar between the two groups.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Caudal Versus Transforaminal Epidural Steroid Injection for Unilateral S1 Radiculopathy. ACE Report. 2023;305(3):16. Available from: https://myorthoevidence.com/AceReport/Show/caudal-versus-transforaminal-epidural-steroid-injection-for-unilateral-s1-radiculopathy

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report